Rabivax-S

BIOLOGICAL5 trials

Conditions

DiarrheaFeverInfluenza-like IllnessMalaria,FalciparumPrevention of Malaria Transmission and Clinical MalariaRabiesRabies Vaccine Adverse ReactionUpper Respiratory Disease

Phase 2

Pfs230D1 + R21 in Matrix-M1 in African School Children and Adults

RecruitingNCT07147400

Serum Institute of India Pvt. Ltd.Prevention of Malaria Transmission and Clinical Malaria

Start: 2025-08-22End: 2027-11-30Target: 1200Updated: 2025-11-19

A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M

Active, not recruitingNCT07183371

University of OxfordMalaria,Falciparum

Start: 2025-12-15End: 2026-12-01Target: 360Updated: 2026-03-11

Phase 4

Non-specific Effects of Rabies Vaccine

CompletedNCT03656198

Ross University School of Veterinary MedicineDiarrhea, Fever, Influenza-like Illness +1

Start: 2018-08-29End: 2020-07-27Updated: 2021-08-13

Safety of Rabivax-S for Pre-exposure Prophylaxis

CompletedNCT03741270

Ross University School of Veterinary MedicineRabies Vaccine Adverse Reaction

Start: 2018-10-24End: 2019-03-28Updated: 2019-09-24

Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and Intradermally

CompletedNCT05937113

Vietnam Military Medical UniversityRabies

Start: 2020-06-13End: 2020-10-30Updated: 2023-07-20

Related Papers

Safety and immunogenicity of an inactivated vero cell-based rabies vaccine (Rabivax-S) in pre-exposure prophylaxis schedule in Vietnam

Clinical and Experimental Vaccine Research2025-01-01

Non-specific effects of rabies vaccine on the incidence of self-reported common infectious disease episodes: A randomized controlled trial.

2021-06-111 citations

Non-specific effects of rabies vaccine on the incidence of common infectious disease episodes: study protocol for a randomized controlled trial.

2020-06-162 citations

Rabivax-S

Sponsors

Conditions

Phase 2

Phase 4

Related Papers